SHALF yields 3.20% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, SHALF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHALF + JNJ for your $10,000?
Shangri-La Asia Limited, an investment holding company, develops, owns/leases, operates, and manages hotels and associated properties worldwide. It operates through four segments: Hotel Properties, Hotel Management and Related Services, Investment Properties, and Property Development for Sale. The company develops, owns, and operates office and commercial properties, and serviced apartments/residences; and operates restaurants and amusement parks. It is also involved in the hotel ownership, and property rental and sale business; and property investment, as well as wines trading activities. The company operates hotels under the Shangri-La Hotels and Resorts, Kerry Hotels, JEN by Shangri-La, Traders Hotel, Rasa, Summer Palace, and Shang Palace, as well as CHI, The Spa at Shangri-La brand names. As of December 31, 2021, it had equity interests in 80 operating hotels and 3 hotels under operating lease with 35,154 rooms. Shangri-La Asia Limited was founded in 1971 and is headquartered in Quarry Bay, Hong Kong.
Full SHALF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.